Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer’s disease
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer’s disease
Authors
Keywords
<sup>123</sup>I-FP-CIT, DAT, SPECT, MIBG myocardial scintigraphy, Alzheimer’s disease, Dementia with Lewy bodies
Journal
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Volume 43, Issue 1, Pages 184-192
Publisher
Springer Nature
Online
2015-08-01
DOI
10.1007/s00259-015-3146-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 123I-MIBG Cardiac Scintigraphy Provides Clues to the Underlying Neurodegenerative Disorder in Idiopathic REM Sleep Behavior Disorder
- (2017) Tomoyuki Miyamoto et al. SLEEP
- Role of Semiquantitative Assessment of Regional Binding Potential in 123I-FP-CIT SPECT for the Differentiation of Frontotemporal Dementia, Dementia With Lewy Bodies, and Alzheimer’s Dementia
- (2015) Timo S. Spehl et al. CLINICAL NUCLEAR MEDICINE
- Diagnostic Accuracy of 123I-Meta-Iodobenzylguanidine Myocardial Scintigraphy in Dementia with Lewy Bodies: A Multicenter Study
- (2015) Mitsuhiro Yoshita et al. PLoS One
- Striatal Dopamine Transporter Binding Does Not Correlate with Clinical Severity in Dementia with Lewy Bodies
- (2013) M. Ziebell et al. JOURNAL OF NUCLEAR MEDICINE
- Clinical and multimodal biomarker correlates of ADNI neuropathological findings
- (2013) Jon B Toledo et al. Acta Neuropathologica Communications
- Combined use of 123I-metaiodobenzylguanidine (MIBG) scintigraphy and dopamine transporter (DAT) positron emission tomography (PET) predicts prognosis in drug-induced Parkinsonism (DIP): A 2-year follow-up study
- (2012) Joong-Seok Kim et al. ARCHIVES OF GERONTOLOGY AND GERIATRICS
- Iodine-123 Metaiodobenzylguanidine Scintigraphy and Iodine-123 Ioflupane Single Photon Emission Computed Tomography in Lewy Body Diseases: Complementary or Alternative Techniques?
- (2012) Giorgio Treglia et al. JOURNAL OF NEUROIMAGING
- Differentiation of frontotemporal dementia from dementia with Lewy bodies using FP-CIT SPECT
- (2012) Shirlony Morgan et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Predictive value of dopamine transporter SPECT imaging with [123I]PE2I in patients with subtle parkinsonian symptoms
- (2011) Morten Ziebell et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- SNM Practice Guideline for Dopamine Transporter Imaging with 123I-Ioflupane SPECT 1.0
- (2011) D. S. W. Djang et al. JOURNAL OF NUCLEAR MEDICINE
- Diagnostic accuracy of 123I-FP-CIT (DaTSCAN) in dementia with Lewy bodies: A meta-analysis of published studies
- (2011) Nikolaos D. Papathanasiou et al. PARKINSONISM & RELATED DISORDERS
- Diagnostic Performance of Myocardial Innervation Imaging Using MIBG Scintigraphy in Differential Diagnosis between Dementia with Lewy Bodies and Other Dementias: A Systematic Review and a Meta-Analysis
- (2010) Giorgio Treglia et al. JOURNAL OF NEUROIMAGING
- Diagnostic accuracy of 123I-FP-CIT SPECT in possible dementia with Lewy bodies
- (2009) John T. O'Brien et al. BRITISH JOURNAL OF PSYCHIATRY
- Physiological Changes in Human Cardiac Sympathetic Innervation and Activity Assessed by 123I-Metaiodobenzylguanidine (MIBG) Imaging
- (2009) Kazuyuki Sakata et al. CIRCULATION JOURNAL
- Combined use of DAT-SPECT and cardiac MIBG scintigraphy in mixed tremors
- (2009) Fabiana Novellino et al. MOVEMENT DISORDERS
- CSF α-synuclein levels in dementia with Lewy bodies and Alzheimer's disease
- (2008) Moeko Noguchi-Shinohara et al. BRAIN RESEARCH
- Cardiac 123I-metaiodobenzylguanidine imaging allows early identification of dementia with Lewy bodies during life
- (2008) Montserrat Estorch et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started